Emerging frontiers of cell-free DNA fragmentomics

Abstract

Analysis of cell-free DNA (cfDNA) in the blood has shown promise for monitoring a variety of biological processes. Plasma cfDNA is a mixture comprising DNA molecules released from various bodily tissues, mediated by characteristic DNA fragmentations occurring during cell death. Fragmentation of cfDNA is non-random and contains tissue-of-origin information, which has been demonstrated in circulating fetal, tumoral, and transplanted organ-derived cfDNA molecules. Many studies have elucidated a plurality of fragmentomic markers for noninvasive prenatal, cancer, and organ transplantation assessment, such as fragment sizes, fragment ends, end motifs, and nucleosome footprints. Recently, researchers have further revealed the large population of previously unidentified long cfDNA molecules (kilobases in size) in the plasma DNA pool. This review focuses on the emerging biological properties of cfDNA, together with a discussion on its potential clinical implications.

Keywords

Plasma DNA / urinary DNA / fragmentomics / pregnancy / oncology / transplantation / virology

References

[1] Lo YMD,Chamberlain PF.Presence of fetal DNA in maternal plasma and serum.Lancet1997;350:485-7

[2] Chiu RWK,Gao Y.Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.Proc Natl Acad Sci USA2008;105:20458-63 PMCID:PMC2600580

[3] van der Meij KR,Macville MV.TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the netherlands.Am J Hum Genet2019;105:1091-101 PMCID:PMC6904791

[4] Chan KCA,Chan CWM.Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.Proc Natl Acad Sci USA2013;110:18761-8 PMCID:PMC3839703

[5] Chan KA,Zheng YW.Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.Clin Chem2013;59:211-24

[6] Jiang P,Chan KCA.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Proc Natl Acad Sci USA2015;112 PMCID:PMC4372002

[7] Phallen J,Adleff V.Direct detection of early-stage cancers using circulating tumor DNA.Sci Transl Med2017;9:eaan2415 PMCID:PMC6714979

[8] Lo YMD,Jiang P.Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies.Science2021;372:eaaw3616

[9] Yu SCY,Chan KCA.Combined count- and size-based analysis of maternal plasma DNA for noninvasive prenatal detection of fetal subchromosomal aberrations facilitates elucidation of the fetal and/or maternal origin of the aberrations.Clin Chem2017;63:495-502

[10] Lo YMD,Sun H.Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.Sci Transl Med2010;2

[11] Zheng YWL,Sun H.Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model.Clin Chem2012;58:549-58

[12] Mouliere F,Piskorz AM.Enhanced detection of circulating tumor DNA by fragment size analysis.Sci Transl Med2018;10:eaat4921 PMCID:PMC6483061

[13] Chan RWY,Peng X.Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing.Proc Natl Acad Sci USA2014;111 PMCID:PMC4267379

[14] Underhill HR,Hellwig S.Fragment length of circulating tumor DNA.PLoS Genet2016;12:e1006162 PMCID:PMC4948782

[15] Diehl F,Dressman D.Detection and quantification of mutations in the plasma of patients with colorectal tumors.Proc Natl Acad Sci USA2005;102:16368-73 PMCID:PMC1283450

[16] Yu SCY,Zheng YWL.Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.Proc Natl Acad Sci USA2014;111:8583-8 PMCID:PMC4060699

[17] Kitzman JO,Ventura M.Noninvasive whole-genome sequencing of a human fetus.Sci Transl Med2012;4 PMCID:PMC3379884

[18] Chan KCA,Sun K.Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends.Proc Natl Acad Sci USA2016;113 PMCID:PMC5167168

[19] Marass F,Ptashkin R.Fragment size analysis may distinguish clonal hematopoiesis from tumor-derived mutations in cell-free DNA.Clin Chem2020;66:616-8 PMCID:PMC7108495

[20] Straver R,Sistermans EA.Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.Prenat Diagn2016;36:614-21 PMCID:PMC5111749

[21] Snyder M,Hill A,Shendure J.Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin.Cell2016;164:57-68 PMCID:PMC4715266

[22] Esfahani MS,Mehrmohamadi M.Inferring gene expression from cell-free DNA fragmentation profiles.Nat Biotechnol2022;40:585-97 PMCID:PMC9337986

[23] Chan D,Hui E.Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma.Ann Oncol2022;33:794-803

[24] Meriranta L,Pasanen A.Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.Blood2022;139:1863-77

[25] Vong JSL,Jiang P.Single-Stranded DNA library preparation preferentially enriches short maternal DNA in maternal plasma.Clin Chem2017;63:1031-7

[26] Burnham P,Agbor-enoh S.Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma.Sci Rep2016;6 PMCID:PMC4906518

[27] Hudecova I,Hänsel-hertsch R.Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.Genome Res2022;32:215-27 PMCID:PMC8805718

[28] Cheng J,Huang W.Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA.iScience2022;25:104554 PMCID:PMC9254344

[29] Sin STK,Deng J.Identification and characterization of extrachromosomal circular DNA in maternal plasma.Proc Natl Acad Sci USA2020;117:1658-65 PMCID:PMC6983429

[30] Sin ST,Ji L.Effects of nucleases on cell-free extrachromosomal circular DNA.JCI Insight2022;7:e156070 PMCID:PMC9089787

[31] Tse OYO,Cheng SH.Genome-wide detection of cytosine methylation by single molecule real-time sequencing.Proc Natl Acad Sci USA2021;118 PMCID:PMC7865158

[32] Yu SCY,Peng W.Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma.Proc Natl Acad Sci USA2021;118 PMCID:PMC8685924

[33] Yu SCY,Qiao R.Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA In plasma.Clin Chem2022:hvac180

[34] Tan G,Schlapbach R.Long fragments achieve lower base quality in Illumina paired-end sequencing.Sci Rep2019;9:2856 PMCID:PMC6393434

[35] Head SR,LaMere SA.Library construction for next-generation sequencing: overviews and challenges.Biotechniques2014;56:61-4, 66, 68, passim PMCID:PMC4351865

[36] Choy LYL,Jiang P.Single-molecule sequencing enables long cell-free DNA detection and direct methylation analysis for cancer patients.Clin Chem2022;68:1151-63

[37] Jiang P,Tong YK.Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.Proc Natl Acad Sci USA2018;115:E10925-33 PMCID:PMC6243268

[38] Bao H,Ma X.Letter to the Editor: an ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.Mol Cancer2022;21:129 PMCID:PMC9188251

[39] Suzuki N,Yamaki J.Characterization of circulating DNA in healthy human plasma.Clin Chim Acta2008;387:55-8

[40] Chandrananda D,Bahlo M.High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.BMC Med Genomics2015;8:29 PMCID:PMC4469119

[41] Serpas L,Jiang P.Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA.Proc Natl Acad Sci USA2019;116:641-9 PMCID:PMC6329986

[42] Han DSC,Chan RWY.The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB.Am J Hum Genet2020;106:202-14 PMCID:PMC7010979

[43] Jiang P,Peng W.Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation.Cancer Discov2020;10:664-73

[44] Zhitnyuk YV,Alferov AA.Deep cfDNA fragment end profiling enables cancer detection.Mol Cancer2022;21:26 PMCID:PMC8780681

[45] Guo W,Liu R.Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.EBioMedicine2022;81:104131 PMCID:PMC9251329

[46] Chan RWY,Ni M.Plasma DNA profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction.Am J Hum Genet2020;107:882-94 PMCID:PMC7674998

[47] Jiang P,Ding SC.Detection and characterization of jagged ends of double-stranded DNA in plasma.Genome Res2020;30:1144-53 PMCID:PMC7462074

[48] Ding SC,Peng W.Jagged ends on multinucleosomal cell-free DNA serve as a biomarker for nuclease activity and systemic lupus erythematosus.Clin Chem2022;68:917-26

[49] Ma ML,Jiang P.Topologic analysis of plasma mitochondrial DNA reveals the coexistence of both linear and circular molecules.Clin Chem2019;65:1161-70

[50] Ma ML,Zhang H.Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: detection and topology.Prenat Diagn2021;41:368-75 PMCID:PMC7984455

[51] Sin STK,Deng J.Characteristics of fetal extrachromosomal circular DNA in maternal plasma: methylation status and clearance.Clin Chem2021;67:788-96

[52] Kumar P,Shibata Y,Jones DR.Normal and cancerous tissues release extrachromosomal circular DNA (eccDNA) into the circulation.Mol Cancer Res2017;15:1197-205 PMCID:PMC5581709

[53] Paulsen T,Koseoglu MM.Discoveries of extrachromosomal circles of DNA in normal and tumor cells.Trends Genet2018;34:270-8 PMCID:PMC5881399

[54] Tsui NB,Chow KC.High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing.PLoS One2012;7:e48319 PMCID:PMC3485143

[55] Zhang J,Li PK.Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism.Clin Chem1999;45:1741-6

[56] Chen M,Cheung PPH.Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.PLoS Genet2022;18:e1010262 PMCID:PMC9258866

[57] Cheng THT,Tam JCW.Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.Clin Biochem2017;50:496-501

[58] Cheng THT,Teoh JYC.Noninvasive detection of bladder cancer by shallow-depth genome-wide bisulfite sequencing of urinary cell-free DNA for methylation and copy number profiling.Clin Chem2019;65:927-36

[59] Zhou Z,Ding SC.Jagged ends of urinary cell-free DNA: characterization and feasibility assessment in bladder cancer detection.Clin Chem2021;67:621-30

[60] Xie T,Ding SC.High-resolution analysis for urinary DNA jagged ends.NPJ Genom Med2022;7:14 PMCID:PMC8866458

[61] Burke DM,O’Reilly PH.The community-based morbidity of flexible cystoscopy.BJU Int2002;89:347-9

[62] Svatek RS,Holmäng S.The economics of bladder cancer: costs and considerations of caring for this disease.Eur Urol2014;66:253-62

[63] Ou Z,Yang T.Detection of bladder cancer using urinary cell-free DNA and cellular DNA.Clin Transl Med2020;9:4 PMCID:PMC6960275

[64] Birkenkamp-Demtröder K,Christensen E.Genomic alterations in liquid biopsies from patients with bladder cancer.Eur Urol2016;70:75-82

[65] Mouliere F,Heider K.Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.EMBO Mol Med2021;13:e12881 PMCID:PMC8350897

[66] Wu X,Shi M.Cerebrospinal fluid cell-free DNA-based detection of high level of genomic instability is associated with poor prognosis in NSCLC patients with leptomeningeal metastases.Front Oncol2022;12:664420 PMCID:PMC9097599

[67] Lo YMD,Lo KW.Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.Cancer Res1999;59:1188-91

[68] Chan KCA,King A.Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer.N Engl J Med2017;377:513-22

[69] Lam WKJ,Chan KCA.Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.Proc Natl Acad Sci USA2018;115:E5115-24 PMCID:PMC5984543

[70] Linthorst J,Sistermans EA.Distinct fragmentation patterns of circulating viral cell-free DNA in 83,552 non-invasive prenatal testing samples.Extracell Vesicles Circ Nucleic Acids2021;

[71] Lui YY,Chiu RW.Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.Clin Chem2002;48:421-7

[72] Sun K,Chan KC.Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.Proc Natl Acad Sci USA2015;112:E5503-12 PMCID:PMC4603482

[73] Moss J,Neiman D.Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease.Nat Commun2018;9:5068 PMCID:PMC6265251

[74] Gai W,Agbor-Enoh S.Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology.Elife2021;10 PMCID:PMC7997656

[75] Lam NY,Chiu RW.EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis.Clin Chem2004;50:256-7

[76] Fernando MR,Norton S.A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage.Prenat Diagn2010;30:418-24

[77] Hisano O,Miura F.Short single-stranded DNAs with putative non-canonical structures comprise a new class of plasma cell-free DNA.BMC Biol2021;19:225 PMCID:PMC8518174

[78] Cheng LY,Wu LR,Zhang DY.Direct capture and sequencing reveal ultra-short single-stranded DNA in biofluids.iScience2022;25:105046 PMCID:PMC9486625